Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece
BackgroundPirfenidone is an antifibrotic compound able to slow down disease progression in patients with idiopathic pulmonary fibrosis (IPF).ObjectiveTo investigate the safety and efficacy of pirfenidone in patients with IPF in a real-life setting.MethodsThis was a multicenter, retrospective, real-l...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2017-11-01
|
| Seri Bilgileri: | Frontiers in Medicine |
| Konular: | |
| Online Erişim: | http://journal.frontiersin.org/article/10.3389/fmed.2017.00213/full |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|